3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase NA
2
Phase 4
1
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
27
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Prostatic Neoplasms
8
Multiple Myeloma
8
Lung Neoplasms
7
Melanoma
6
Stomach Neoplasms
5
Leukemia, Myeloid, Acute
5
Neoplasm Metastasis
4
Glioma
4
Colorectal Neoplasms
4
Carcinoma, Hepatocellular
4
Tuberous Sclerosis
3
Sarcoma
3
Papillomavirus Infections
3
Leiomyoma
3
Hematologic Neoplasms
3
Glioblastoma
3
Carcinoma, Renal Cell
3
Warts
2
Venous Thromboembolism
2
Thyroid Neoplasms
2
Skin Neoplasms
2
Rectal Neoplasms
2
Polycythemia Vera
2
Pain, Postoperative
2
Pain
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Interventions
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cytokine Release Syndrome
×
90 days
×
Clear all
NCT07609940
2026-05-27
POPLIN
Regeneron Pharmaceuticals
Phase 4
Not yet recruiting
30 enrolled